Efficacy of cognitive pragmatic treatment in adults with schizophrenia

被引:1
|
作者
Muthu, Anusuya [1 ]
Nambi, Shanthi [2 ]
Krishnan, Raman [2 ]
Vijayaraghavan, Rajagopalan [3 ]
机构
[1] Saveetha Med Coll & Hosp, Dept Speech Language & Hearing Sci ENT, Chennai, Tamil Nadu, India
[2] Saveetha Med Coll & Hosp, Dept Psychiat, Chennai, Tamil Nadu, India
[3] Saveetha Inst Med & Tech Sci, Dept Res & Dev, Chennai, Tamil Nadu, India
关键词
Schizophrenia; cognitive pragmatic treatment; cognitive functioning; pragmatic language impairment; group therapy; social communication impairment; ANTIPSYCHOTIC MEDICATION; LANGUAGE; DEFICITS; EXPRESSION; THERAPY; SKILLS;
D O I
10.54905/disssi/v27i132/e100ms2828
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: The study aimed to evaluate the efficiency of cognitive-pragmatic treatment (CPT) in improving cognitive functions and pragmatic language abilities in adults with schizophrenia. Methods: 100 individuals with schizophrenia who fulfilled the inclusion criteria were assigned to control (n = 25) and experimental groups (n = 75). Experimental groups received CPT for 3 months, while the control group obtained only routine care. Individuals were tested both before and after the intervention to gauge their progress also 3 months post-intervention, a follow-up evaluation was carried out. Analyses employed parametric and non-parametric statistics. Results: The findings revealed significant variations among groups and tests (p<0.001), & interaction of groups with tests (p<0.001) on two-way Repeated Measures ANOVA. Both the post-test and the follow-up assessment indicated that the experimental group had significantly higher levels of pragmatic language skills and cognitive functioning than the control group. There has been no major influence of age, gender and illness duration on the treatment outcomes by three-way ANOVA. Conclusions: The present study showed that CPT improved pragmatic language communication skills & cognitive functioning in adults with schizophrenia.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Treatment of Cognitive Impairment in Schizophrenia.
    Vita, A.
    EUROPEAN PSYCHIATRY, 2022, 65 : S48 - S49
  • [32] COGNITIVE-BEHAVIORAL TREATMENT OF SCHIZOPHRENIA
    PENN, DL
    MUESER, KT
    BEHAVIORAL PSYCHOLOGY-PSICOLOGIA CONDUCTUAL, 1995, 3 (01): : 5 - 33
  • [33] Guanfacine Treatment of Cognitive Impairment in Schizophrenia
    Joseph I Friedman
    David N Adler
    Humberto D Temporini
    Eileen Kemether
    Philip D Harvey
    Leonard White
    Michael Parrella
    Kenneth L Davis
    Neuropsychopharmacology, 2001, 25 : 402 - 409
  • [34] Cognitive Behavioral Therapy in Treatment of Schizophrenia
    Kart, Aysegul
    Ozdel, Kadir
    Turkcapar, Mehmet Hakan
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2021, 58 : S61 - S65
  • [36] COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
    Millgate, Edward
    Kravariti, Eugenia
    MacCabe, James
    Hide, Olga
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S56 - S57
  • [37] Cognitive therapy for schizophrenia: Treatment and dissemination
    Marcinko, L
    Read, M
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (18) : 2269 - 2275
  • [38] Cognitive deficits as treatment targets in schizophrenia
    Gold, JM
    SCHIZOPHRENIA RESEARCH, 2004, 72 (01) : 21 - 28
  • [39] Cognitive-behavioral treatment of schizophrenia
    Tarrier, N
    Barrowclough, C
    Haddock, G
    COMPREHENSIVE TREATMENT OF SCHIZOPHRENIA: LINKING NEUROBEHAVIORAL FINDINGS TO PSYCHOSOCIAL APPROACHES, 2002, : 382 - 391
  • [40] 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia
    de Bruin, Natasja M. W. J.
    Kruse, Chris G.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (26) : 3739 - 3759